Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy induced nausea and vomiting

D N Carney

    Irish Medical Journal
    |September 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Identifying effective antiemetic agents is crucial for managing chemotherapy-induced nausea and vomiting (CINV). While significant progress has been made, further research is needed to optimize treatments, especially for delayed CINV.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Osteosarcoma and second malignant neoplasms: a case series.

    Irish journal of medical science·2019
    Same author

    Is chemotherapy always required for cancer in pregnancy? An observational study.

    Irish journal of medical science·2017
    Same author

    Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy.

    Irish medical journal·2016
    Same author

    Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review.

    Clinical sarcoma research·2015
    Same author

    Primary bone lymphoma: single institution case series.

    Irish journal of medical science·2008
    Same author

    Predictive testing for BRCA1 and 2 mutations: a male contribution.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Chemotherapy-induced nausea and vomiting (CINV) is a significant and disabling side effect of cancer treatment.
    • Numerous factors, including patient demographics, cancer type, prior treatments, and administration details, complicate the evaluation of clinical trials for CINV management.

    Discussion:

    • The development of various antiemetic drug classes has substantially improved CINV prevention.
    • Despite advancements, challenges remain in fully eliminating CINV and addressing delayed onset symptoms.

    Key Insights:

    • Patient-specific factors and treatment variables significantly influence the occurrence and severity of CINV.
    • Optimizing antiemetic strategies requires careful consideration of these multifactorial influences.

    Outlook:

    Related Experiment Videos

    • Further clinical trials are essential to refine antiemetic agent selection and scheduling.
    • Future research should focus on overcoming the persistent challenge of delayed chemotherapy-induced nausea and vomiting.